Also, presence of CD56+CD16− NK and M2-like macrophages in primary tumor sites or circulating in the peripheral blood have been recently identified as crucial for development of metastasis, invasion, and treatment resistance [51, 52]. Here, NCAM1 is linked to neoplasm.